ALGN

Nasdaq

ALIGN TECHNOLOGY INC

Health Care, Health Care Supplies

$173.66

close 7 Aug 2026

+28.81%

52-week change

$12.37B

market cap

$122.00

$200.44

52-week range

Valuation

Market cap$12.37B

P/E (TTM / 5y avg)30.25x43.98x

Forward P/E (FY2026 / FY2027)15.38x13.84x

PEG (TTM / fwd)4.311.38

P/S (TTM)2.99x

P/B2.92x

EV/EBITDA (TTM)—

FCF yield (TTM)5.12%

Cash flow & dividend

FCF (TTM)$633.57M

FCF per share (TTM)$8.89

FCF margin (TTM)15.31%

Dividend yield (indicated / 5y avg)——

Annualized dividend—

Payout ratio (EPS / FCF)——

Growth & quality

Revenue YoY, latest Q+4.32%

Diluted EPS YoY, latest Q-12.21%

Operating margin (TTM)13.23%

Net margin (TTM)9.99%

ROE (latest FY)10.13%

Net debt / EBITDA (TTM)—

Interest coverage (TTM)—

Price

-74.88%-24.21%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +10.30%10Y CAGR +16.92%

Diluted EPS

5Y CAGR -24.09%10Y CAGR +12.31%

FCF per share

5Y CAGR +1.09%10Y CAGR +11.54%

Operating cash flow

5Y CAGR -2.18%10Y CAGR +9.56%

Free cash flow

5Y CAGR -0.66%10Y CAGR +10.28%

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR -1.98%10Y CAGR -1.07%

Net debt / EBITDA

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date28 Oct 2026amc

EPS estimate$2.90

Revenue estimate$1.04B

Last reported

Date—

EPS——

Revenue——